Page last updated: 2024-08-25

zoledronic acid and Epstein-Barr Virus Infections

zoledronic acid has been researched along with Epstein-Barr Virus Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altvater, B; Bisping, G; Bollard, CM; Hansmeier, A; Juergens, H; Landmeier, S; Moosmann, A; Pscherer, S; Rossig, C; Varnholt, L	1

Other Studies

1 other study(ies) available for zoledronic acid and Epstein-Barr Virus Infections

Article	Year
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer. Journal of immunotherapy (Hagerstown, Md. : 1997), 2009, Volume: 32, Issue:3 Topics: Antigen-Presenting Cells; Antigens, Viral; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Diphosphonates; Epitopes; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Imidazoles; Immunotherapy; Receptors, Antigen, T-Cell, gamma-delta; Transduction, Genetic; Tumor Necrosis Factor-alpha; Zoledronic Acid	2009

Article

Year

Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.

Journal of immunotherapy (Hagerstown, Md. : 1997), 2009, Volume: 32, Issue:3

Topics: Antigen-Presenting Cells; Antigens, Viral; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Diphosphonates; Epitopes; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Imidazoles; Immunotherapy; Receptors, Antigen, T-Cell, gamma-delta; Transduction, Genetic; Tumor Necrosis Factor-alpha; Zoledronic Acid

2009